Basic Information
Basic information for LINC00917-217-22aa-1
Peptide Name LINC00917-217-22aa-1
Genome Position chr16:86332009-86332074[-]
Species Human
Peptide Sequence MHHYIPTHSGCVNPASHRITGW
Peptide Length 22
Unique No (LINC00917-201-22aa-1,LINC00917-202-22aa-1,LINC00917-204-22aa-2,LINC00917-206-22aa-1,LINC00917-207-22aa-1,LINC00917-208-22aa-1,LINC00917-209-22aa-1,LINC00917-210-22aa-2,LINC00917-211-22aa-2,LINC00917-212-22aa-2,LINC00917-213-22aa-1,LINC00917-214-22aa-1,LINC00917-215-22aa-1)
Grand Average of Hydropathicity -0.4818
Relative Molecular Mass 2880.22
Experimental Evidences no
lncRNA ID/Name ENSG00000168367;LINC00917
Transcript ID/Name ENST00000670118;LINC00917-217
Transcript Length 2513
Coding Ability 0.3645
DNA Sequence Corresponding to Peptide ATGCACCATTACATCCCCACTCACTCGGGCTGTGTGAACCCAGCAAGTCACAGGATCACTGGGTGG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :